Fueling New Knowledge of Infectious Disease Dynamics
What We Do
UCI Infectious Disease Science Initiative aims to position UCI as a global leader in research and education in infectious disease dynamics by fueling the development of new knowledge and insights into the dynamics of infectious diseases and drug resistance. The Initiative will seek to use data science to answer questions about what factors drive and sustain infectious disease outbreaks and what can be done to predict and prevent the emergence and re-emergence of infectious diseases.
There are no upcoming events at this time.
COVID-19 Statistics Portal
News and Announcements
UCI Law Video: Law & Policy in the Biden-Harris Administration: Civil … Read More about IDSI FAB member Professor Michele Goodwin on “Civil Liberties in a Pandemic: The Lessons of History”
Co-Sponsor, UCI Infectious Disease Science Initiative presents COVID-19 One … Read More about COVID-19 One Year into the Pandemic: UCI’s Scientific Contributions.
Follow us on Twitter
"Immunogenicity of SARS‐CoV‐2 BNT162b2 vaccine in solid organ transplant recipients" https://onlinelibrary.wiley.com/doi/10.1111/ajt.16607
A reason, when virus transmission is still high and especially with B.1.1.7 variant, I typically wear a mask in public or when with others. As we head towards greater vaccine coverage in US about 75% by June, transmission will slow and masks less essential https://www.cnn.com/2021/04/14/health/breakthrough-infections-covid-vaccines-cdc/index.html
Check out the article by IDSI FAB member Dr. Daniel Parker and many UCI faculty.
"Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California"
Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
Clinic-based estimates of SARS-CoV-2 may considerably underestimate the total number of infections. Access to testing in...